PASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Arrowhead Research Corp. (ARWR) on Monday reported a loss of $173.1 million in its fiscal first quarter.
The Pasadena, California-based company said it had a loss of $1.39 per share.
The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.
The drug developer posted revenue of $2.5 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $169.6 million.
Arrowhead Research shares have climbed nearly 7% since the beginning of the year. In the final minutes of trading on Monday, shares hit $20.04, a decrease of 35% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARWR at https://www.zacks.com/ap/ARWR
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.